Mysoline and Oxycontin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mysoline (primidone) and Oxycontin (oxycodone hydrochloride). Common drug interactions include osteosclerosis among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Mysoline and Oxycontin. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Mysoline?

Mysoline has active ingredients of primidone. It is often used in essential tremor. eHealthMe is studying from 2,849 Mysoline users. Check the latest studies of Mysoline.

What is Oxycontin?

Oxycontin has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 212,533 Oxycontin users. Check the latest studies of Oxycontin.



On Jul, 08, 2026

45 people who take Mysoline and Oxycontin together, and have interactions are studied.

Mysoline and Oxycontin drug interactions.

What are the common drug interactions of Mysoline and Oxycontin, by gender? *:

female:

  1. Osteosclerosis (an elevation in bone density)
  2. Pain in jaw
  3. Decreased appetite
  4. Inflammation
  5. Asthenia (weakness)
  6. Oedema peripheral (superficial swelling)
  7. Constipation
  8. Swelling face
  9. Depression
  10. Insomnia (sleeplessness)

male:

  1. Gait disturbance
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Aortic dilatation
  4. Arrhythmia (irregular heartbeat)
  5. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  6. Arteriovenous fistula site complication
  7. Arthralgia (joint pain)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Bone disorder

What are the common drug interactions of Mysoline and Oxycontin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Decreased appetite
  3. Depression
  4. Disturbance in attention
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Memory impairment
  7. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Oedema peripheral (superficial swelling)
  9. Speech disorder
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

30-39:

n/a

40-49:

  1. Drug addiction
  2. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

50-59:

  1. Hypotension (abnormally low blood pressure)
  2. Otitis media chronic (long lasting inflammation of the middle ear)
  3. Abscess neck (neck abscesses)
  4. Addison's disease (addison's disease, a hormonal disorder disease)
  5. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  6. Anaemia of chronic disease
  7. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Bone disorder

60+:

  1. Aortic arteriosclerosis (hardening of the aortic arteries)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Pain in jaw
  4. Confusional state
  5. Constipation
  6. Dyspnoea (difficult or laboured respiration)
  7. Abdominal pain
  8. Actinic keratosis (skin disease due to sun exposure)
  9. Alveolar osteitis (complication of wound healing following extraction of a tooth)
  10. Anxiety

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 12 people, 26.67%
  2. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 11 people, 24.44%
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood): 6 people, 13.33%
  4. Depression: 4 people, 8.89%
  5. Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 6.67%
  6. Osteoporosis (bones weak and more likely to break): 3 people, 6.67%
  7. High Blood Pressure: 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Mysoline and Oxycontin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mysoline and Oxycontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mysoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mysoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycontin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on primidone and oxycodone hydrochloride (the active ingredients of Mysoline and Oxycontin, respectively), and Mysoline and Oxycontin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: